ascidiacyclamide has been researched along with Leukemia P388 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asano, A; Doi, M; Numata, A; Yamada, T | 1 |
| Asano, A; Doi, M; Hasegawa, H; Ishida, T; Katsuya, Y; Mezaki, Y; Minoura, K; Nakai, M; Numata, A; Sasaki, M; Taniguchi, T; Terashima, A; Yamada, T | 1 |
2 other study(ies) available for ascidiacyclamide and Leukemia P388
| Article | Year |
|---|---|
Cyclo(-Cha-Oxz-D-Val-Thz-Ile-Oxz-D-Val-Thz-) N,N-dimethylacetamide dihydrate: a square form of cyclohexylalanine-incorporated ascidiacyclamide having the strongest cytotoxicity.
Topics: Amino Acids; Animals; Cell Line, Tumor; Circular Dichroism; Crystallography, X-Ray; Cytotoxins; Leukemia P388; Mice; Molecular Structure; Peptides, Cyclic; Protein Folding | 2003 |
Effect of asymmetric modification on the conformation of ascidiacyclamide analogs.
Topics: Amino Acid Substitution; Animals; Antineoplastic Agents; Circular Dichroism; Crystallography, X-Ray; Dimethyl Sulfoxide; Leukemia P388; Leukemia, Lymphoid; Magnetic Resonance Spectroscopy; Molecular Conformation; Peptides, Cyclic; Solvents; Temperature; Tumor Cells, Cultured | 2002 |